Detalhe da pesquisa
1.
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Gastroenterol Hepatol
; 46(10): 764-773, 2023 Dec.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36731726
2.
Living with gout. Experiences, impact and challenges of the disease. Qualitative study through focus groups.
Reumatol Clin (Engl Ed)
; 19(3): 150-158, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058814
3.
The impact of gout as described by patients, using the lens of The International Classification of Functioning, Disability and Health (ICF): a qualitative study.
BMC Rheumatol
; 4: 50, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32832854
4.
Vivir con gota. Experiencias, impacto y retos de la enfermedad. Estudio cualitativo mediante grupos focales / Living with gout. Experiences, impact and challenges of the disease. Qualitative study through focus groups
Reumatol. clín. (Barc.)
; 19(3): 150-158, Mar. 2023. tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-217290
5.
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels) / Los inhibidores de mTOR como potencial factor predisponente para la hepatitis crónica E: resultados del estudio prospectivo colaborativo CHES (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels)
Gastroenterol. hepatol. (Ed. impr.)
; 46(10): 764-773, dic. 2023. tab
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-228224